PinneyAssociates Offering Webinar on Abuse Potential Assessment of Cannabinoids

The development of novel pharmaceuticals whose pharmacology is dependent on cannabinoid receptors is an increasingly active area of research and development.  However, the confusing and conflicting legal status of cannabis and its active constituents can inhibit development, as companies encounter significant and unique barriers to approval and appropriate scheduling.

The Controlled Substances Act (CSA) describes eight factors that need to be examined in order to assess the abuse potential of substances that are active within the central nervous system (CNS).  These factors encompass a wide range of topics regarding the substance, including the totality of its physical and behavioral effects, consequences more at


Leave a Reply